ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2016

Jan 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2016-01-01

Reporting Person: PERRY MICHAEL S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-01	Common Stock	A	30000	$0.00	Acquired	75000	Direct

Footnotes

F1: Represents shares underlying a restricted stock unit, which shares will vest on the one year anniversary of the date of grant.